The Xanthine Oxidase Inhibitor Febuxostat Suppresses Development of Nonalcoholic Steatohepatitis in a Rodent Model
American Journal of Physiology - Gastrointestinal and Liver Physiology - United States
doi 10.1152/ajpgi.00443.2014
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2015
Authors
Publisher
American Physiological Society